Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Sarcoma, Ewing × eribulin × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 13 Triple Negative Breast Neoplasms 6 Neoplasm Metastasis 3 Urinary Bladder Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Recurrence 1 Hemangiosarcoma 1 Hemangioendothelioma, Epithelioid 1 HER2-low Breast Cancer 1 Carcinoma, Transitional Cell 1 Brest Cancer 1 Brain Neoplasms 1

Interventions

Temozolomide 8 Vincristine 7 Irinotecan 6 Cyclophosphamide 6 Etoposide 5 Specimen Handling 4 Ifosfamide 4 Doxorubicin 4 regorafenib 3 Radiotherapy 3 Radiation 3 Magnetic Resonance Spectroscopy 3 ivosidenib 2 fludarabine 2 etoposide phosphate 2 cabozantinib 2 abemaciclib 2 X-Rays 2 Topotecan 2 Surgical Procedures, Operative 2 Sirolimus 2 Phantoms, Imaging 2 PM 01183 2 Melphalan 2 Eflornithine 2 Congresses as Topic 2 Biopsy 2 ulixertinib 1 tipifarnib 1 tazemetostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡